ŠŤASTNÁ-MARKOVÁ, M.; PECHERKOVÁ, P.; NĚMEČKOVÁ, Š.; KRYŠTOFOVÁ, J.; VANÍKOVÁ, Š.; VYDRA, J.; ROUBALOVÁ, K.^G Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. Transplant immunology. 2025, vol. 88, no. February,art. no. 102166. ISSN 0966-3274.